Smith Mary L.

Insider profile

Smith Mary L.'s trades of PTC Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
240.25
Quantity 66,889 -41.0%
Value US$3,055,666
Transaction date
Planned sale
Price
288.59
Quantity 58,906 -1.5%
Value US$3,911,652
Transaction date
Proposed sale
Price
187.28
Quantity 41,791
Value US$2,353,870
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-09
PlS Planned sale
66,889 -41.0%
240.25
US$3,055,666 		66,889 -41.0% 240.25 US$3,055,666
2026-07-13 2026-07-09
PlS Planned sale
58,906 -1.5%
288.59
US$3,911,652 		58,906 -1.5% 288.59 US$3,911,652
2026-07-09 2026-07-09
PrS Proposed sale
41,791
187.28
US$2,353,870 		41,791 187.28 US$2,353,870